ScienceDex / Researcher record
Balveen Kaur
- Augusta University · Pathology (NIH department code)
- Augusta University · Neurosurgery (NIH department code)
- Brigham and Women's Hospital · Neurosurgery (investigator's affiliation)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
FY2025 NIH rank #9,902
- Program Leader
- R01 Holder
- Early Career
- Diverse Portfolio
NIH Funding · FY2025
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $1,535,303 | 4 | #8,314 |
| 2025 | $1,516,249 | 4 | #9,902 |
| 2026 | $3,122,885 | 4 | #5,799 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20244 records
- FY2025 · selected4 records
- FY20264 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8464810Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0001-7738-0804Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Pathology
- Neurosurgery
FY2025 award records by amount
NIH award records listing Balveen Kaur as a PI. Multi-PI records show the full award amount for context.
- 5R01NS137577-02R01Contact PINext generation oncolytic virotherapy targeting AKT and ERK signaling in gliomaAugusta University · Pathology (NIH department code)$550.4Kaward amount
- 5R01NS127473-04R01Contact PINext Gen Virotherapy for GBMAugusta University · Pathology (NIH department code)$529.6Kaward amount
- 5R61NS128191-02R61Contact PIDevelopment of murine glioblastoma model for oncolytic HSV therapyAugusta University · Neurosurgery (NIH department code)$375.2Kaward amount
- 5P01CA163205-13P01Contact PICircumventing Barriers to Effective Oncolytic Virotherapy of Malignant GliomasBrigham and Women's Hospital · Neurosurgery (investigator's affiliation)$61.2Kaward amount
Award organizations
Organizations that administered FY2025 awards listing Balveen Kaur as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardAugusta University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #8314
- 2025$2M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Balveen Kaur.
E. Antonio Chiocca
Brigham and Women's Hospital
3
shared awards
Joseph C Glorioso
Brigham and Women's Hospital
3
shared awards
Keith Lloyd Ligon
Brigham and Women's Hospital
3
shared awards
Michael A Caligiuri
Brigham and Women's Hospital
3
shared awards
William F. Goins
Brigham and Women's Hospital
3
shared awards
Xiaokui Mo
Brigham and Women's Hospital
3
shared awards
Bangxing B Hong
Augusta University
2
shared awards
Bangxing B Hong
Lsu Health Sciences Center
1
shared award